silicon and Renal-Insufficiency

silicon has been researched along with Renal-Insufficiency* in 3 studies

Reviews

1 review(s) available for silicon and Renal-Insufficiency

ArticleYear
[Imbalance of trace elements in uremic patients].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 6

    Topics: Aluminum; Humans; Renal Dialysis; Renal Insufficiency; Selenium; Silicon; Trace Elements; Uremia; Vanadium; Zinc

2004

Other Studies

2 other study(ies) available for silicon and Renal-Insufficiency

ArticleYear
Ultrasensitive Silicon Nanowire Biosensor with Modulated Threshold Voltages and Ultra-Small Diameter for Early Kidney Failure Biomarker Cystatin C.
    Biosensors, 2023, Jun-13, Volume: 13, Issue:6

    Acute kidney injury (AKI) is a frequently occurring severe disease with high mortality. Cystatin C (Cys-C), as a biomarker of early kidney failure, can be used to detect and prevent acute renal injury. In this paper, a biosensor based on a silicon nanowire field-effect transistor (SiNW FET) was studied for the quantitative detection of Cys-C. Based on the spacer image transfer (SIT) processes and channel doping optimization for higher sensitivity, a wafer-scale, highly controllable SiNW FET was designed and fabricated with a 13.5 nm SiNW. In order to improve the specificity, Cys-C antibodies were modified on the oxide layer of the SiNW surface by oxygen plasma treatment and silanization. Furthermore, a polydimethylsiloxane (PDMS) microchannel was involved in improving the effectiveness and stability of detection. The experimental results show that the SiNW FET sensors realize the lower limit of detection (LOD) of 0.25 ag/mL and have a good linear correlation in the range of Cys-C concentration from 1 ag/mL to 10 pg/mL, exhibiting its great potential in the future real-time application.

    Topics: Biomarkers; Biosensing Techniques; Cystatin C; Humans; Nanowires; Renal Insufficiency; Silicon; Transistors, Electronic

2023
Renal handling of silicon in normals and patients with renal insufficiency.
    Kidney international, 1992, Volume: 42, Issue:4

    We have compared the renal handling of silicon in 16 patients with renal insufficiency to 14 normal individuals. Silicon, phosphate and creatinine were measured in plasma and urine samples. The renal insufficiency group showed significant increases in plasma silicon (1.28 +/- 0.19 vs. 0.17 +/- 0.03 mg/liter), creatinine (5.19 +/- 0.85 vs. 0.89 +/- 0.03 mg/dl) and phosphate (1.33 +2- 0.11 vs. 1.07 +/- 0.4 mmol/liter). Fractional phosphate excretion was increased in the renal insufficiency group (0.55 +/- 0.07 vs. 0.14 +/- 0.01). In contrast, the fractional excretion of ultrafiltrable silicon was not significantly different between groups (0.78 +/- 0.07 vs. 0.87 +/- 0.06). It is concluded that renal insufficiency does not alter the tubular handling of silicon and that regulatory control of silicon excretion is unlikely.

    Topics: Creatinine; Female; Humans; Kidney; Male; Phosphates; Renal Insufficiency; Silicon

1992